Copyright © Qilu Pharmaceutical (Hainan) Co., Ltd. 琼ICP备14000953号 Powered by www.300.cn
WeChat public number
Hangzhou AoYa biotechnology limited company to visit Hainan
In June 4th, Hangzhou AoYa biotechnology limited company chairman Huang Shaofeng to lead the company production, quality and other relevant person in charge for a 9 people came to Hainan to visit the company, general manager of the Hainan company Liu Wenmin, deputy general manager Lian Wei and other leaders warmly received Huang Dong and his party.
On the first floor of the sand table, general manager Liu Wenmin introduced the basic situation of Hainan's geographical location, size, layout of workshop to the guests, and development planning of Qilu group is briefly introduced. Came to the meeting room, the administrative staff of the Department carried out a detailed introduction of Qilu group and Hainan's development, the scale of production, GMP management, drug development, products and so on, let the guests with a more comprehensive understanding of Hainan company. Subsequently, Hangzhou AoYa biotechnology limited company staff also has carried on the introduction to the basic situation of the company.
In the following exchange, both sides mainly in Hainan in the FDA certification process, prosecutors to focus on the content, especially on matters of facilities, equipment, file system, operation and training and other aspects need to pay attention to exchanges. At the same time, Hangzhou AoYa biotechnology limited company will also be their good work experience, management methods and the Hainan company to share. Chairman Huang Shaofeng said: the exchanges of visits by this time, they have benefited, will conscientiously sum up the exchange of experience, but also hope that the Hainan company do better more, go to the forefront of the national pharmaceutical industry.